Thermo Fisher Scientific Palivizumab Humanized Recombinant Human Monoclonal Antibody

Thermo Fisher Scientific Palivizumab Humanized Recombinant Human Monoclonal Antibody

Applications

• ELISA

Tested Dilution: 1:5,000–1:10,000

Product Specifications

Product Specific Information

• Endotoxin level: < 0.01 EU/µg (LAL method)
• Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Store at 2–8°C for one week.
• Store at -20 to -80°C for twelve months from the date of receipt.

Target Information

Palivizumab (trade name Synagis) is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa monoclonal antibody that binds the RSV envelope fusion protein (RSV F) on the virus surface, blocking a critical step in the membrane fusion process.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.